Genetic Testing: Consent and Result Disclosure for Primary Care Providers
- PMID: 31582007
- PMCID: PMC6779337
- DOI: 10.1016/j.mcna.2019.07.001
Genetic Testing: Consent and Result Disclosure for Primary Care Providers
Abstract
Historically, both pretest and posttest genetic counseling has been standard of care for genetic testing. This model should be adapted for primary care providers (PCPs) willing to learn critical information about the test and key concepts that patients need to make an informed testing decision. It is helpful for PCPs to discuss a few initial patients with a genetic counselor to prepare for the key concepts of pretest and posttest counseling. This article provides guidance about the recommended level of involvement of PCPs based on the test indication, test complexity, disorder management, and the potential for psychosocial sequela.
Keywords: CADRe; ClinGen; Genetic testing; Genomic testing; Informed consent; Return of results.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
DISCLOSURE STATEMENT
Disclose any relationship with a commercial company that has a direct financial interest in subject matter or materials discussed in article or with a company making a competing product. If nothing to disclose, please state “The Authors have nothing to disclose.” The authors have nothing to disclose.
Figures
References
-
- National Society of Genetic Counselors: Genetic Counselor Workforce Initiatives. Available at: http://www.nsgc.org/p/cm/ld/fid=532. Accessed October 5, 2017.
-
- Summar Marshall L., MS Watson LDTs, Incidental Findings, and the Need for More Geneticists. Medscape. November 2015. Available at http://www.medscape.com/viewarticle/853979 Accessed September 27, 2017.
-
- Cooksey JA, Forte G, Flanagan PA, Benkendorf J, Blitzer MG. The medical genetics workforce: An analysis of clinical geneticist subgroups. Genet Med. 2006;8(10):603–614. - PubMed
-
- Ringwald J, Wochnowski C, Bosse K, Giel KE, Schäffeler N, Zipfel S, Teufel M. Psychological distress, anxiety, and depression of cancer-affected BRCA 1/2 mutation carriers: A systematic review. J Genet Couns. 2016;25(5):880–91. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
